MELPHALAN for Neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 16 adverse event reports in the FDA FAERS database where MELPHALAN was used for Neoplasm.
Most Reported Side Effects for MELPHALAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 2,002 | 12.5% | 437 | 495 |
| Febrile neutropenia | 931 | 5.8% | 145 | 419 |
| Drug ineffective | 853 | 5.3% | 199 | 213 |
| Neutropenia | 810 | 5.0% | 145 | 246 |
| Mucosal inflammation | 804 | 5.0% | 131 | 254 |
| Plasma cell myeloma | 781 | 4.9% | 223 | 99 |
| Product use in unapproved indication | 765 | 4.8% | 144 | 182 |
| Thrombocytopenia | 701 | 4.4% | 118 | 253 |
| Diarrhoea | 698 | 4.4% | 95 | 343 |
| Pyrexia | 667 | 4.2% | 144 | 346 |
| Pneumonia | 650 | 4.1% | 254 | 382 |
| Disease progression | 595 | 3.7% | 155 | 90 |
| Myelodysplastic syndrome | 573 | 3.6% | 231 | 132 |
| Sepsis | 544 | 3.4% | 316 | 247 |
| Venoocclusive liver disease | 464 | 2.9% | 152 | 130 |
Other Indications for MELPHALAN
Plasma cell myeloma (4,878)
Bone marrow conditioning regimen (2,368)
Product used for unknown indication (963)
Stem cell transplant (738)
Retinoblastoma (715)
Diffuse large b-cell lymphoma (595)
Neuroblastoma (495)
Allogenic stem cell transplantation (374)
Hodgkin's disease (351)
Autologous haematopoietic stem cell transplant (284)
Other Drugs Used for Neoplasm
BEVACIZUMAB (502)
ATEZOLIZUMAB (404)
CYCLOPHOSPHAMIDE (385)
CARBOPLATIN (283)
PACLITAXEL (267)
NIVOLUMAB (219)
OXALIPLATIN (185)
PEMBROLIZUMAB (173)
LENALIDOMIDE (171)
DOXORUBICIN (150)